Biotech platform for the detection of airborne viruses

Our cost-effective, reusable and near real-time technology provides vulnerable populations and healthcare professionals with a tool for accurate identification of exposure to viral hazards before the symptom onset.

OUR MISSION

Revolutionise screening and prevention to proactively respond to health threats and enhance global well-being

We are a dedicated team of biotechnology and software engineers committed to addressing the global challenge of frequent respiratory disease outbreaks. By harnessing the power of cutting-edge technologies, we develop pre-symptomatic diagnostic devices for viral infections as an alternative to existing analytical platforms that are bulky, expensive and require qualified personnel to interpret the results.

Why choose VAir?

Flexibility

Our device allows the integration of multiple detection modules with different capture elements to simultaneously detect multiple airborne viruses, such as SARS-CoV-2, respiratory syncytial virus, or influenza.
Convenience

Unlike existing aerosol analyzers necessitating additional biochemical assays for pathogen identification, our technology leverages highly specific antibody-antigen binding. This approach allows for automatic and accurate identification of pathogens without the need for manual intervention.
Affordability

The lower cost and simple maintenance make our platform affordable for individuals, small enterprises, and healthcare facilities, as opposed to commercially available biodefense devices targeted at large military actors.

Discover our partners

VAir is incubated at the Drahi-X Novation Center as part of its X-Up Create programme, and is a member of the École Polytechnique ecosystem.

FAQ

We have successfully developed the technical concept and are in the process of validating our PoC under controlled laboratory conditions in collaboration with the Engineering for Health Interdisciplinary Centre (E4H). Looking ahead, we plan to conduct field trials of our technology in 2025. By 2026, we anticipate launching our first product, a collective alert system, in the EU market.

If you are interested in participating in the field testing of our prototype or wish to collaborate on our R&D activities, please do not hesitate to contact us.
Yes. Our technology involves the use of nanobodies that are specifically designed to target the corresponding antigens of different virus species, with each detection module dedicated to one virus type. While our current technology does not allow the identification of unknown viral species in the air, we can adapt our biomanufacturing process to detect new viruses as their genome sequences are determined. This adaptability allows us to respond quickly to emerging viral threats.
Yes. The modularity of our devices enables a wide range of configurations, allowing for seamless integration into existing ventilation, air conditioning, and air quality monitoring systems. This flexibility ensures that VAir devices can be adapted to enhance the functionality of current systems by adding advanced viral detection capabilities.

If you are interested in exploring how our solutions can augment your existing products, please do not hesitate to contact us for more information.
In addition to push notifications sent through our mobile application, we provide a diverse range of notification options to meet various communication needs. Our system supports text messages, emails, and web hooks, ensuring that you receive timely updates in your preferred format. If you have specific needs or would like to suggest a customized integration with a software of your choice, please do not hesitate to contact us!
VAir offers two payment models to accommodate different customer preferences. The first option is a fixed price offer which includes the sale of our devices and biodetection modules for the viruses of interest. Customers will pay a fixed price based on the number of devices and modules purchased. This price takes into account the cost of research and development (R&D), production, our operational expenses and the desired profit margin.

In addition, we will offer a monthly subscription for the maintenance of our devices and software. This will include regular updates, performance checks and technical support from our teams to ensure the smooth and continuous operation of the devices.

As our products are currently in the R&D stage, we cannot provide exact pricing at this time. However, our goal is to offer better value for money compared to existing aerosol bio-analyzers, which typically start at prices around $20,000 and often lack specificity for different virus species.

We are also conducting a market study to refine our offerings based on the needs and preferences of potential clients. If you are interested in the VAir products and considering using them in your workplace or home, please contact us. We value your input and engagement as we continue to develop our technology.

Biotech platform for the detection of airborne viruses

Our cost-effective, reusable and near real-time technology provides vulnerable populations and healthcare professionals with a tool for accurate identification of exposure to viral hazards before the symptom onset.

OUR MISSION

Revolutionise screening and prevention to proactively respond to health threats and enhance global well-being

Why choose VAir?

Flexibility

Convenience

Affordability

Discover our partners

FAQ

What is the stage of development of your products?

Can VAir systems detect different types of viruses?

Can VAir devices be integrated into existing HVAC or air quality monitoring systems?

What types of notifications do VAir systems offer?

What are the payment models for VAir products?